Search

everythinglearnresearchcommunity

for

Search:↓

Improved Finasteride delivery for hair loss treatment.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

The new drug delivery system effectively targets lung cancer cells.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Peptide drugs now target hard-to-reach proteins more effectively and specifically.

Semifluorinated alkanes are promising for delivering drugs in various medical applications.

Polysaccharide-based niosomes improve drug delivery and show promise in cancer therapy but face challenges in scalability and stability.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Nanomaterials could improve PCOS treatment by delivering drugs more effectively with fewer side effects.

Solidified SEDDS improve drug stability and bioavailability better than liquid SEDDS.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Tadalafil and Finasteride may help treat aggressive melanoma.

Potential new drugs for treating PCOS were identified.

One Ashwagandha extract may help protect cells with its antioxidant properties, while another could promote hair growth.

The antidepressant escitalopram likely caused hair loss in a patient.

Laser-assisted drug delivery is generally safe with mostly mild side effects.

Using existing drugs for new purposes can effectively treat infections resistant to multiple antibiotics.

Nanocarriers can improve skin drug delivery but face challenges in clinical use.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

The new drug delivery system improves exemestane's absorption and effectiveness.

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

Standardized guidelines are needed to improve drug-loaded extracellular vesicle purification.

Marine biomaterials show promise for drug delivery and wound healing.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Nanocarriers can improve the effectiveness of herbal medicines in treating colorectal cancer.

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

CG2001 is safe and well-tolerated for treating hair loss in men.

Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.